These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20551403)

  • 81. Local Ablative Therapy Options for Patients with Inoperable Pancreatic Cancer.
    Strunk HM; Marinova M
    Radiology; 2017 Aug; 284(2):604-605. PubMed ID: 28723296
    [No Abstract]   [Full Text] [Related]  

  • 82. In reply to Oskan.
    Chang JY
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1142. PubMed ID: 25035223
    [No Abstract]   [Full Text] [Related]  

  • 83. In reply to Cihoric and Jeremic.
    Cho BC
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1112-3. PubMed ID: 25832705
    [No Abstract]   [Full Text] [Related]  

  • 84. In Regard to Nagata et al.
    Milisavljevic S; Spasic M
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1219-20. PubMed ID: 27026321
    [No Abstract]   [Full Text] [Related]  

  • 85. Stereotactic body radiotherapy for central lung tumours: Author reply.
    Adebahr S; Collette S; Shash E; Lambrecht M; Le Pechoux C; Faivre-Finn C; De Ruysscher D; Peulen H; Belderbos J; Dziadziuszko R; Fink C; Guckenberger M; Hurkmans C; Nestle U
    Br J Radiol; 2015 Sep; 88(1053):20150532. PubMed ID: 26151618
    [No Abstract]   [Full Text] [Related]  

  • 86. Delivering safe and effective stereotactic body radiation therapy for patients with centrally located early stage non-small cell lung cancer.
    Haseltine JM; Rimner A; Shepherd AF; Wu AJ; Gelblum DY; Shaverdian N; Gomez DR; Simone CB
    Chin Clin Oncol; 2020 Jun; 9(3):39. PubMed ID: 32008333
    [No Abstract]   [Full Text] [Related]  

  • 87. Patient-reported Outcomes With Stereotactic Body Radiotherapy and Surgery for Lung Cancer.
    Vogel J; Simone CB
    Clin Lung Cancer; 2020 May; 21(3):e229-e230. PubMed ID: 31953027
    [No Abstract]   [Full Text] [Related]  

  • 88. The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer?
    Rusthoven CG; Palma DA; Senan S; Kavanagh BD
    J Clin Oncol; 2017 May; 35(15):1749-1751. PubMed ID: 28221860
    [No Abstract]   [Full Text] [Related]  

  • 89. Stereotactic Body Radiation Therapy and Surgery for Early Stage Non-Small Cell Lung Cancer.
    Piperis M; Tsoukalas N
    J Invest Surg; 2018 Oct; 31(5):448-449. PubMed ID: 29083938
    [No Abstract]   [Full Text] [Related]  

  • 90. Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer.
    Zhang T; Yu H; Ni C; Zhang T; Liu L; Lv Q; Zhang Z; Wang Z; Wu D; Wu P; Chen G; Wang L; Wei Q; Huang J; Wang X
    Sci Rep; 2017 Jul; 7(1):4866. PubMed ID: 28687760
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Stage I Stereotactic Body Radiation Therapy Outcome's Prediction Models: Perfection Is the Enemy of Utility.
    Ramella S; Soda P
    J Thorac Oncol; 2023 Mar; 18(3):262-264. PubMed ID: 36842809
    [No Abstract]   [Full Text] [Related]  

  • 92. The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    Moghanaki D; Simone CB; Rimner A; Karas TZ; Donington J; Shirvani SM; Daly M; Videtic GM; Movsas B;
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):429-431. PubMed ID: 29245205
    [No Abstract]   [Full Text] [Related]  

  • 93. Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.
    Ozsahin M; Slotman BJ; Bourhis J
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):233-234. PubMed ID: 31422814
    [No Abstract]   [Full Text] [Related]  

  • 94. Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer: in regard to Ge et al.
    Kumar SM; Laviraj MA; Rath GK
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):5. PubMed ID: 23755920
    [No Abstract]   [Full Text] [Related]  

  • 95. Requirements and Implementation of a Lung SBRT Program in a Developing Country: Benefits of International Cooperation.
    Khader J; Al-Mousa A; Hijla FA; Al-Heet S; Rashdan I; Balter P; Chang J; Wadi-Ramahi S
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1236-8. PubMed ID: 27354130
    [No Abstract]   [Full Text] [Related]  

  • 96. CHISELing a path forward in the treatment of early-stage non-small-cell lung cancer.
    AlShafa F; Palma D
    Lancet Oncol; 2019 Apr; 20(4):461-463. PubMed ID: 30770293
    [No Abstract]   [Full Text] [Related]  

  • 97. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer.
    Moghissi K
    Thorax; 1992 Apr; 47(4):327. PubMed ID: 1316640
    [No Abstract]   [Full Text] [Related]  

  • 98. Commentary: Keeping surgery relevant in oligometastatic non-small cell lung cancer.
    Donington JS
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1629-1630. PubMed ID: 30538030
    [No Abstract]   [Full Text] [Related]  

  • 99. SABR-COMET: harbinger of a new cancer treatment paradigm.
    Loo BW; Diehn M
    Lancet; 2019 May; 393(10185):2013-2014. PubMed ID: 30982688
    [No Abstract]   [Full Text] [Related]  

  • 100. SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise.
    Kamrava M; Chino JP; Beriwal S
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):472-474. PubMed ID: 32014146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.